Congenital heart disease: addressing the need for novel lower-risk percutaneous interventional strategies

References

• Ferrari L, Leahy I, Staffa SJ, et al. The pediatric-specific american society of anesthesiologists physical status score: a multicenter study. Anesth Analg. 2021;132(3):807–817.
   PubMed Web of Science ®Google Scholar
• Jenkins KJ, Gauvreau K, Newburger JW, et al. Consensus-based method for risk adjustment for surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2002;123(1):110–118.
   PubMed Web of Science ®Google Scholar
• Lacour-Gayet F, Clarke D, Jacobs J, et al. The Aristotle score: a complexity-adjusted method to evaluate surgical results. Eur J Cardiothorac Surg. 2004;25(6):911–924. DOI:10.1016/j.ejcts.2004.03.027
   PubMed Web of Science ®Google Scholar
• Al-Radi OO, Harrell FE, Caldarone CA, et al. Case complexity scores in congenital heart surgery: a comparative study of the Aristotle Basic Complexity score and the Risk Adjustment in Congenital Heart Surgery (RACHS-1) system. J Thorac Cardiovasc Surg. 2007;133(4):865–875. DOI:10.1016/j.jtcvs.2006.05.071
   PubMed Web of Science ®Google Scholar
• Jacobs ML, Jacobs JP, Jenkins KJ, et al. Stratification of complexity: the risk adjustment for congenital heart surgery-1 method and the aristotle complexity score – past, present, and future. Cardiol Young. 2008;18(S2):163–168.
   PubMedGoogle Scholar
• O’Brien SM, Clarke DR, Jacobs JP, et al. An empirically based tool for analyzing mortality associated with congenital heart surgery. J Thorac Cardiovasc Surg. 2009;138(5):1139–1153. DOI:10.1016/j.jtcvs.2009.03.071
   PubMed Web of Science ®Google Scholar
• Brown KL, Crowe S, Franklin R, et al. Trends in 30-day mortality rate and case mix for paediatric cardiac surgery in the UK between 2000 and 2010. Open Heart. 2015;2(1):e000157. DOI:10.1136/openhrt-2014-000157
   PubMedGoogle Scholar
• Crowe S, Brown KL, Pagel C, et al. Development of a diagnosis- and procedure-based risk model for 30-day outcome after pediatric cardiac surgery. J Thorac Cardiovasc Surg. 2013;145(5):1270–1278. DOI:10.1016/j.jtcvs.2012.06.023
   PubMed Web of Science ®Google Scholar
• Mehta R, Lee K-J, Chaturvedi R, et al. Complications of pediatric cardiac catheterization: a review in the current era. Catheterization Cardiovasc Interventions. 2008;72(2):278–285.
   PubMed Web of Science ®Google Scholar
• Cassidy SC, Schmidt KG, Van Hare GF, et al. Complications of pediatric cardiac catheterization: a 3-year study. J Am Coll Cardiol. 1992;19(6):1285–1293.
   PubMed Web of Science ®Google Scholar
• STANGER PH, TARNOFF H, HOFFMAN JI, et al. Complications of cardiac catheterization of neonates, infants, and children: a three-year study. Circulation. 1974 Sep;50(3):595–608.
   PubMed Web of Science ®Google Scholar
• Vitiello R, McCrindle BW, Nykanen D, et al. Complications associated with pediatric cardiac catheterization. J Am Coll Cardiol. 1998;32(5):1433–1440.
   PubMed Web of Science ®Google Scholar
• Huang YC, Lai YC, Lai Y-C. Li PC Importance of prevention and early intervention of adverse events in pediatric cardiac catheterization: a review of three years of experience. Pediatr Neonatol. 2009 Dec;50(6):280–286.
   PubMed Web of Science ®Google Scholar
• Tokel K, Gümüş A, Ayabakan C, et al. Complications of cardiac catheterization in children with congenital heart disease. Turk J Pediatr. 2018;60(6):675.
   PubMed Web of Science ®Google Scholar
• Lin CH, Hegde S, Marshall AC, et al. Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol. 2014;35(1):140–148. DOI:10.1007/s00246-013-0752-y
   PubMed Web of Science ®Google Scholar
• Rhodes JA, Blaufox AD, Sommer RJ. Impact of low body weight on frequency of pediatric cardiac catheterization complications. Am J Cardiol. 2000 Dec;1(11):1275–1278.
   Google Scholar
• Zeevi B, Berant M, Fogelman R, et al. Acute complications in the current era of therapeutic cardiac catheterization for congenital heart disease. Cardiol Young. 1999;9(3):266–272.
   PubMed Web of Science ®Google Scholar
• Bergersen L, Marshall A, Gauvreau K, et al. Adverse event rates in congenital cardiac catheterization - A multi-center experience. In: Catheterization and Cardiovascular Interventions. 2010;75(3):389–400. DOI:10.1002/ccd.22266
   Google Scholar
• Bergersen L, Gauvreau K, Foerster SR, et al. Catheterization for Congenital Heart Disease Adjustment for Risk Method (CHARM). JACC Cardiovasc Interv. 2011;4(9):1037–1046. DOI:10.1016/j.jcin.2011.05.021.
   PubMed Web of Science ®Google Scholar
• Jayaram N, Beekman RH, Benson L, et al. Adjusting for risk associated with pediatric and congenital cardiac catheterization. Circulation. 2015;132(20):1863–1870. DOI:10.1161/CIRCULATIONAHA.114.014694
   PubMed Web of Science ®Google Scholar
• Nykanen DG, Forbes TJ, Du W, et al. CRISP: catheterization risk score for pediatrics: a report from the congenital cardiac interventional study consortium (CCISC). Catheterization Cardiovasc Interventions. 2016;87(2):302–309. DOI:10.1002/ccd.26300.
   PubMed Web of Science ®Google Scholar
• Hill KD, Du W, Fleming GA, et al. Validation and refinement of the catheterization RISk score for pediatrics (CRISP score): an analysis from the congenital cardiac interventional study consortium. Catheterization Cardiovasc Interventions. 2019;93(1):97–104. DOI:10.1002/ccd.27837
   PubMed Web of Science ®Google Scholar
• O’Callaghan B, Shepherd E, Taliotis D, et al. Validating a risk assessment tool in United Kingdom and Irish paediatric cardiac catheterisation practice. Cardiol Young. 2022;32(9):1407–1414. DOI:10.1017/S1047951121004170
   Web of Science ®Google Scholar
• Giorgione V, Parazzini F, Fesslova V, et al. Congenital heart defects in IVF/ICSI pregnancy: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(1):33–42. DOI:10.1002/uog.18932
   PubMed Web of Science ®Google Scholar
• Reig AS, Seli E. The association between assisted reproductive technologies and low birth weight. Curr Opin Obstet Gynecol. 2019 Jun;31(3):183–187.
   PubMed Web of Science ®Google Scholar
• Kalfa D, Krishnamurthy G, Duchon J, et al. Outcomes of cardiac surgery in patients weighing <2.5 kg: affect of patient-dependent and -independent variables. J Thorac Cardiovasc Surg. 2014;148(6):2499–506.e1. DOI:10.1016/j.jtcvs.2014.07.031
   PubMed Web of Science ®Google Scholar
• Krishnamurthy G. Cardiopulmonary bypass in premature and low birth weight neonates - implications for postoperative care from a neonatologist/intensivist perspective. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2019;22:2–9.
   PubMedGoogle Scholar
• Curzon CL, Milford-Beland S, Li JS, et al. Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the society of thoracic surgeons congenital heart database. J Thorac Cardiovasc Surg. 2008;135(3):546–551. DOI:10.1016/j.jtcvs.2007.09.068
   PubMed Web of Science ®Google Scholar
• William Gaynor WTM J, Cohen MI, Ittenbach RF, et al. Risk factors for mortality after the Norwood procedure. Eur J Cardiothorac Surg. 2002;22(1):82–89.
   PubMed Web of Science ®Google Scholar
• Ades AM, Dominguez TE, Nicolson SC, et al. Morbidity and mortality after surgery for congenital cardiac disease in the infant born with low weight. Cardiol Young. 2010;20(1):8–17. DOI:10.1017/S1047951109991909
   PubMed Web of Science ®Google Scholar
• Alarcon Manchego P, Cheung M, Zannino D, et al. Audit of cardiac surgery outcomes for low birth weight and premature infants. Semin Thorac Cardiovasc Surg. 2018;30(1):71–78.
   PubMed Web of Science ®Google Scholar
• Pawade AW, Laussen P, Karl TR, et al. Cardiopulmonary bypass in neonates weighing less than 2.5 kg: analysis of the risk factors for early and late mortality. J Card Surg. 1993 Jan;8(1):1–8.
   PubMed Web of Science ®Google Scholar
• Aykanat A, Yavuz T, Özalkaya E, et al. Long-term prostaglandin e1 infusion for newborns with critical congenital heart disease. Pediatr Cardiol. 2016;37(1):131–134.
   PubMed Web of Science ®Google Scholar
• Dorobantu DM, Pandey R, Sharabiani MT, et al. Indications and results of systemic to pulmonary shunts: results from a national database. Eur J Cardiothorac Surg. 2016;49(6):1553–1563. DOI:10.1093/ejcts/ezv435
   PubMed Web of Science ®Google Scholar
• Gibbs JL, Rothman MT, Rees MR, et al. Stenting of the arterial duct: a new approach to palliation for pulmonary atresia. Heart. 1992;67(3):240–245.
   Web of Science ®Google Scholar
• Bentham JR, Zava NK, Harrison WJ, et al. Duct stenting versus modified blalock-taussig shunt in neonates with duct-dependent pulmonary blood flow. Circulation. 2018;137(6):581–588. DOI:10.1161/CIRCULATIONAHA.117.028972
   PubMed Web of Science ®Google Scholar
• Glatz AC, Petit CJ, Goldstein BH, et al. Comparison between patent ductus arteriosus stent and modified blalock-taussig shunt as palliation for infants with ductal-dependent pulmonary blood flow. Circulation. 2018;137(6):589–601. DOI:10.1161/CIRCULATIONAHA.117.029987
   PubMed Web of Science ®Google Scholar
• Mallula K, Vaughn G, El-Said H, et al. Comparison of ductal stenting versus surgical shunts for palliation of patients with pulmonary atresia and intact ventricular septum. Catheterization Cardiovasc Interventions. 2015;85(7):1196–1202.
   PubMed Web of Science ®Google Scholar
• Petrucci O, O’Brien SM, Jacobs ML, et al. Risk factors for mortality and morbidity after the neonatal blalock-taussig shunt procedure. Ann Thorac Surg. 2011;92(2):642–652.
   PubMed Web of Science ®Google Scholar
• Nasef MA, Shahbah DA, Batlivala SP, et al. Short‐ and medium‐term outcomes for patent ductus arteriosus stenting in neonates ≤2.5 kg with duct‐dependent pulmonary circulation. Catheterization Cardiovasc Interventions. 2022;100(4):596–605. DOI:10.1002/ccd.30351.
   PubMedGoogle Scholar
• Ravndal MEA, Christensen AH, Døhlen G, et al. Paediatric cardiac catheterisation in Norway: rates and types of complications in new terms. Cardiol Young. 2017;27(7):1329–1335.
   PubMed Web of Science ®Google Scholar
• Costello JM, Kim F, Polin R, et al. Double jeopardy: prematurity and congenital heart disease-what’s known and why it’s important. World J Pediatr Congenit Heart Surg. 2022;13(1):65–71.
   PubMed Web of Science ®Google Scholar
• Tanner K, Sabrine N, Wren C. Cardiovascular malformations among preterm infants. Pediatrics. 2005;116(6):e833–8.
   PubMed Web of Science ®Google Scholar
• Costello JM, Polito A, Brown DW, et al. Birth before 39 weeks’ gestation is associated with worse outcomes in neonates with heart disease. Pediatrics. 2010;126(2):277–284. DOI:10.1542/peds.2009-3640
   PubMed Web of Science ®Google Scholar
• Costello JM, Pasquali SK, Jacobs JP, et al. Gestational age at birth and outcomes after neonatal cardiac surgery. Circulation. 2014;129(24):2511–2517. DOI:10.1161/CIRCULATIONAHA.113.005864
   PubMed Web of Science ®Google Scholar
• Cnota JF, Gupta R, Michelfelder EC, et al. Congenital heart disease infant death rates decrease as gestational age advances from 34 to 40 weeks. J Pediatr. 2011;159(5):761–765.
   PubMed Web of Science ®Google Scholar
• Steurer MA, Baer RJ, Keller RL, et al. Gestational age and outcomes in critical congenital heart disease. Pediatrics. 2017;140(4).
   PubMed Web of Science ®Google Scholar
• Alkashkari W, Albugami S, Hijazi ZM. Current practice in atrial septal defect occlusion in children and adults. Expert Rev Cardiovasc Ther. 2020;18(6):315–329.
   PubMed Web of Science ®Google Scholar
• Weisz DE, More K, McNamara PJ, et al. PDA ligation and health outcomes: a meta-analysis. Pediatrics. 2014;133(4):e1024–46.
   PubMed Web of Science ®Google Scholar
• Baruteau AE, Hascoet S, Baruteau J, et al. Transcatheter closure of patent ductus arteriosus: past, present and future. Arch Cardiovasc Dis. 2014;107(2):122–132. DOI:10.1016/j.acvd.2014.01.008
   PubMed Web of Science ®Google Scholar
• Backes CR, Bridge JA, Armstrong AK, et al. Percutaneous Patent Ductus Arteriosus (PDA) closure during infancy: a meta-analysis. Pediatrics. 2017 Feb;139(2). DOI:10.1542/peds.2016-2927.
   PubMed Web of Science ®Google Scholar
• Dimas VV, Takao C, Ing FF, et al. Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing. JACC: Cardiovasc Interv. 2010;3(12):1295–1299. DOI:10.1016/j.jcin.2010.08.022
   PubMed Web of Science ®Google Scholar
• Abadir S, Boudjemline Y, Rey C, et al. Significant persistent ductus arteriosus in infants less or equal to 6 kg: percutaneous closure or surgery? Arch Cardiovasc Dis. 2009;102(6–7):533–540. DOI:10.1016/j.acvd.2009.04.004
   PubMed Web of Science ®Google Scholar
• Francis E, Singhi AK, Lakshmivenkateshaiah S, et al. Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC: Cardiovasc Interv. 2010;3(5):550–555.
   PubMed Web of Science ®Google Scholar
• Abu Hazeem AA, Gillespie MJ, Thun H, et al. Percutaneous closure of patent ductus arteriosus in small infants with significant lung disease may offer faster recovery of respiratory function when compared to surgical ligation. Catheterization Cardiovasc Interventions. 2013;n/a–n/a.
   Web of Science ®Google Scholar
• Chen ZW, Luo YK, Lin CG, et al. Comparison of long-term clinical outcome between transcatheter Amplatzer occlusion and surgical closure of isolated patent ductus arteriosus. Chin Med J (Engl). 2009 May;20(122(10):1123–1127.
   Google Scholar
• Bentham J, Meur S, Hudsmith L, et al. Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheterization Cardiovasc Interventions. 2011;77(3):409–415.
   PubMed Web of Science ®Google Scholar
• Baspinar O, Sahin DA, Sulu A, et al. Transcatheter closure of patent ductus arteriosus in under 6 kg and premature infants. J Interv Cardiol. 2015;28(2):180–189. DOI:10.1111/joic.12196
   PubMed Web of Science ®Google Scholar
• Bass JL, Wilson N. Transcatheter occlusion of the patent ductus arteriosus in infants: experimental testing of a new Amplatzer device. Catheterization Cardiovasc Interventions. 2014;83(2):250–255.
   PubMed Web of Science ®Google Scholar
• Sungur M, Karakurt C, Ozbarlas N, et al. Closure of patent ductus arteriosus in children, small infants, and premature babies with Amplatzer duct occluder II additional sizes: multicenter study. Catheterization Cardiovasc Interventions. 2013;82(2):245–252.
   PubMed Web of Science ®Google Scholar
• Kenny D, Morgan GJ, Bentham JR, et al. Early clinical experience with a modified amplatzer ductal occluder for transcatheter arterial duct occlusion in infants and small children. Catheterization Cardiovasc Interventions. 2013;n/a–n/a.
   Web of Science ®Google Scholar
• Sathanandam SK, Gutfinger D, O’Brien L, et al. Amplatzer Piccolo Occluder clinical trial for percutaneous closure of the patent ductus arteriosus in patients ≥700 grams. Catheterization Cardiovasc Interventions. 2020;96(6):1266–1276. DOI:10.1002/ccd.28973.
   PubMed Web of Science ®Google Scholar
• Qureshi AM, Caldarone CA, Wilder TJ. Transcatheter approaches to palliation for tetralogy of fallot. Semin Thorac Cardiovasc Surg Pediatr Card Surg Ann. 2022;25:48–57.
   PubMedGoogle Scholar
• Linnane N, Nasef MA, McMahon CJ, et al. Right ventricular outflow tract stenting in symptomatic infants without the use of a long delivery sheath. Catheter Cardiovasc Interv. 2021;98(2):E275–81. DOI:10.1002/ccd.29708
   PubMed Web of Science ®Google Scholar
• Quandt D, Ramchandani B, Penford G, et al. Right ventricular outflow tract stent versus BT shunt palliation in Tetralogy of Fallot. Heart. 2017;103(24):1985–1991. DOI:10.1136/heartjnl-2016-310620
   PubMed Web of Science ®Google Scholar
• Sandoval JP, Chaturvedi RR, Benson L, et al. Right ventricular outflow tract stenting in tetralogy of fallot infants with risk factors for early primary repair. Circ Cardiovasc Interventions. 2016;9(12):e003979. DOI:10.1161/CIRCINTERVENTIONS.116.003979
   PubMed Web of Science ®Google Scholar
• Backes CH, Cua C, Kreutzer J, et al. Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv. 2013;82(5):786–794. DOI:10.1002/ccd.24726
   PubMed Web of Science ®Google Scholar
• Linnane N, Walsh KP, McGuinness J, et al. Evolution of approach to right ventricular outflow tract stenting in infants ≤ 2Kgs. J Struct Heart Dis. 2018;4(2):50–55.
   Google Scholar
• Zampi JD, Armstrong AK, Hirsch-Romano JC. Hybrid perventricular pulmonary valve perforation and right ventricular outflow stent placement: a case report of a premature, 1.3-kg neonate with tetralogy of Fallot and pulmonary atresia. World J Pediatr Congenit Heart Surg. 2014;5(2):338–341.
   PubMedGoogle Scholar
• Ng LY, Al-Alawi K, Breatnach C, et al. Hybrid subxiphoid perventricular approach as an alternative access in neonates and small children undergoing complex congenital heart interventions. Pediatr Cardiol. 2021;42(3):526–532. DOI:10.1007/s00246-020-02510-z
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Jalal Z, Tamisier D, et al. Dilatable pulmonary artery band: safety and efficacy of balloon dilatation. Catheterization Cardiovasc Interventions. 2016;88(3):446–451.
   PubMed Web of Science ®Google Scholar
• Takayama H, Sekiguchi A, Chikada M, et al. Mortality of pulmonary artery banding in the current era: recent mortality of PA banding. Ann Thorac Surg. 2002;74(4):1219–1224.
   PubMed Web of Science ®Google Scholar
• Bonnet D, Corno AF, Sidi D, et al. Early clinical results of the telemetric adjustable pulmonary artery banding FloWatch-PAB. Circulation. 2004;110(11_suppl_1):158–163. DOI:10.1161/01.CIR.0000138222.43197.1e
   Web of Science ®Google Scholar
• Changizi A, Yaghoubi A, Azarasa M, et al. A study on the mortality and complication rates following percutaneously adjustable pulmonary artery banding. J Cardiovasc Thorac Res. 2014;6(4):253–255.
   PubMedGoogle Scholar
• Brown S, Boshoff D, Rega F, et al. Dilatable pulmonary artery banding in infants with low birth weight or complex congenital heart disease allows avoidance or postponement of subsequent surgery. Eur J Cardiothorac Surg. 2010;37(2):296–301.
   PubMed Web of Science ®Google Scholar
• El-Said H, Hamzeh R, Lamberti J, et al. Catheter balloon adjustment of the pulmonary artery band: feasibility and safety. Pediatr Cardiol. 2011;32(1):8–16.
   PubMed Web of Science ®Google Scholar
• Tomita H, Fujii T, Kise H, et al. Percutaneous pulmonary artery debanding. J Cardiol. 2021;77(3):307–312. DOI:10.1016/j.jjcc.2020.10.021
   PubMed Web of Science ®Google Scholar
• Morgan GJ, Chen Q, Parry A, et al. Balloon debanding the pulmonary artery: in vitro studies and early clinical experience. Congenit Heart Dis. 2009;4(4):273–277.
   PubMed Web of Science ®Google Scholar
• Mollet A, Stos B, Bonnet D, et al. Development of a device for transcatheter pulmonary artery banding: evaluation in animals. Eur Heart J. 2006;27(24):3065–3072.
   PubMed Web of Science ®Google Scholar
• Yayoi Nakahata HT, Kimura S, Ando H, et al. Masahiro Ishii1. Percutaneous bilateral pulmonary artery banding using a re-expandable covered stent: preliminary animal study. Kitasato Med J. 2011;41:165–169.
   Google Scholar
• Gorenflo M, Gewillig M. A flow restrictor implanted percutaneously across a loose pulmonary artery band. Catheterization Cardiovasc Interventions. 2011;77(5):696–699.
   PubMed Web of Science ®Google Scholar
• Khan AH, Hoskoppal D, Kumar TKS, et al. Utility of the Medtronic microvascular plug™ as a transcatheter implantable and explantable pulmonary artery flow restrictor in a swine model. Catheterization Cardiovasc Interventions. 2019;93(7):1320–1328. DOI:10.1002/ccd.28162
   PubMed Web of Science ®Google Scholar
• Nageotte S, Shahanavaz S, Eghtesady P, et al. Total transcatheter stage 1: a word of caution. Pediatr Cardiol. 2021;42(6):1410–1415.
   PubMed Web of Science ®Google Scholar
• Mai CT, Isenburg JL, Canfield MA, et al. National population-based estimates for major birth defects, 2010-2014. Birth Defects Res. 2019;111(18):1420–1435. DOI:10.1002/bdr2.1589
   PubMed Web of Science ®Google Scholar
• Elahi MD, Firmin R, Hickey M. Direct complications of repeat median sternotomy in adults. Asian Cardiovasc Thorac Ann. 2005;13(2):135–138.
   PubMedGoogle Scholar
• Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000;356(9239):1403–1405. DOI:10.1016/S0140-6736(00)02844-0
   PubMed Web of Science ®Google Scholar
• Alkashkari W, Albugami S, Abbadi M, et al. Transcatheter pulmonary valve replacement in pediatric patients. Expert Rev Med Devices. 2020;17(6):541–554.
   PubMed Web of Science ®Google Scholar
• Li WF, Pollard H, Karimi M, et al. Comparison of valvar and right ventricular function following transcatheter and surgical pulmonary valve replacement. Congenit Heart Dis. 2018;13(1):140–146. DOI:10.1111/chd.12544
   PubMed Web of Science ®Google Scholar
• Sharma V, Griffiths ER, Eckhauser AW, et al. Pulmonary valve replacement: a single-institution comparison of surgical and transcatheter valves. Ann Thorac Surg. 2018;106(3):807–813. DOI:10.1016/j.athoracsur.2018.04.002
   PubMed Web of Science ®Google Scholar
• Chatterjee A, Bajaj NS, McMahon WS, et al. Transcatheter pulmonary valve implantation: a comprehensive systematic review and meta‐analyses of observational studies. J Am Heart Assoc. 2017;6(8). DOI:10.1161/JAHA.117.006432.
   Web of Science ®Google Scholar
• Cheatham JP, Hellenbrand WE, Zahn EM, et al. Clinical and hemodynamic outcomes up to 7 years after transcatheter pulmonary valve replacement in the us melody valve investigational device exemption trial. Circulation. 2015;131(22):1960–1970. DOI:10.1161/CIRCULATIONAHA.114.013588
   PubMed Web of Science ®Google Scholar
• Kenny D, Rhodes JF, Fleming GA, et al. 3-Year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the COMPASSION multicenter clinical trial. JACC: Cardiovasc Interv. 2018;11(19):1920–1929. DOI:10.1016/j.jcin.2018.06.001
   PubMed Web of Science ®Google Scholar
• Duignan S, Ryan A, Burns B, et al. Complex decision making in the pediatric catheterization laboratory: catheterizer, know thyself and the data. Pediatr Cardiol. 2018;39(7):1281–1289.
   PubMed Web of Science ®Google Scholar
• Duignan S, Walsh KP, McMahon CJ. Decision-making in the catheter laboratory: the most important variable in successful outcomes. Pediatr Cardiol. 2020;41(3):459–468.
   PubMed Web of Science ®Google Scholar
• Srinivasan C, Sachdeva R, Morrow WR, et al. Standardized management improves outcomes after the norwood procedure. Congenit Heart Dis. 2009;4(5):329–337. DOI:10.1111/j.1747-0803.2009.00323.x
   PubMed Web of Science ®Google Scholar
• Burstein DS, Jacobs JP, Li JS, et al. Care models and associated outcomes in congenital heart surgery. Pediatrics. 2011;127(6):e1482–9. DOI:10.1542/peds.2010-2796
   PubMed Web of Science ®Google Scholar
• Sunstrom RE, Muralidaran A, Gerrah R, et al. A defined management strategy improves early outcomes after the fontan procedure: the portland protocol. Ann Thorac Surg. 2015;99(1):148–155. DOI:10.1016/j.athoracsur.2014.06.121
   PubMed Web of Science ®Google Scholar
• Price MJ, Hawkins JA, McGough EC, et al. Critical pathways for postoperative care after simple congenital heart surgery. Am J Manag Care. 1999 Feb;5(2):185–192.
   PubMed Web of Science ®Google Scholar
• Porras D, Brown DW, Rathod R, et al. Acute Outcomes after Introduction of a Standardized Clinical Assessment and Management Plan (SCAMP) for Balloon Aortic Valvuloplasty in Congenital Aortic Stenosis. Congenit Heart Dis. 2014;9(4):316–325. DOI:10.1111/chd.12142
   PubMed Web of Science ®Google Scholar
• Justino H. Radiation safety in the cardiac catheterization laboratory is our responsibility. Circ Cardiovasc Interventions. 2020;13(5). DOI:10.1161/CIRCINTERVENTIONS.120.009236
   PubMed Web of Science ®Google Scholar
• Quinn BP, Cevallos P, Armstrong A, et al. Longitudinal improvements in radiation exposure in cardiac catheterization for congenital heart disease. Circ Cardiovasc Interventions. 2020;13(5).
   PubMed Web of Science ®Google Scholar
• Morgan GJ. Echocardiographic guidance for neonatal right ventricular outflow tract stent implantation. Congenit Heart Dis. 2013;8(6):585–588.
   PubMed Web of Science ®Google Scholar
• Velasco Forte MN, Roujol S, Ruijsink B, et al. MRI for guided right and left heart cardiac catheterization: a prospective study in congenital heart disease. J Magn Reson Imaging. 2021;53(5):1446–1457. DOI:10.1002/jmri.27426
   PubMed Web of Science ®Google Scholar
• Moore P. MRI-guided congenital cardiac catheterization and intervention: the future? Catheterization Cardiovasc Interventions. 2005;66(1):1–8.
   PubMed Web of Science ®Google Scholar